Concourse Financial Group Securities, Inc. Nanobiotix S.A. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NBTX
# of Institutions
13Shares Held
6MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$21.5 Million6.69% of portfolio
-
Black Rock Inc. New York, NY239KShares$915,4000.0% of portfolio
-
Perceptive Advisors LLC New York, NY105KShares$402,3520.02% of portfolio
-
Jane Street Group, LLC New York, NY11.4KShares$43,6120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$39,0040.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $134M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...